文献速递产科母胎医学

三种市售胎盘生长因子检测在疑似早产子痫前期妇女中的比较:COMPARE研究

Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-12-05

该研究为对三项前瞻性妊娠队列研究样本的回顾性分析,比较三种基于胎盘生长因子(PlGF)的检测在预测疑似早产子痫前期妇女(<35周)检测后14天内分娩的表现。结果显示三种检测的AUC、敏感性、阳性预测值和阴性预测值均无显著差异,Elecsys sFlt-1/PlGF比值检测的特异性高于其他两种检测。

要点

  • 三种PlGF检测预测14天内分娩的AUC无显著差异(P=0.795)。
  • Elecsys sFlt-1/PlGF比值检测特异性高于其他两种检测(P<0.001)。
  • 高阴性预测值支持PlGF检测作为子痫前期的排除工具。

核心结论

  • 三种检测在预测疑似子痫前期妇女14天内分娩需求方面表现相似。
  • 高阴性预测值支持PlGF检测作为子痫前期的排除工具。

研究设计与样本

  • 对三项前瞻性妊娠队列研究收集的样本进行回顾性分析。
  • 参与者为在英国和爱尔兰三级产科单位招募的疑似早产子痫前期孕妇。
  • 样本按制造商说明同时检测,比较DELFIA Xpress PlGF 1-2-3、Triage PlGF和Elecsys sFlt-1/PlGF比值三种检测。
  • 主要结局指标为检测后14天内分娩的AUC差异0.05。
  • 检测了396名妇女的血浆样本和244名妇女的血清样本。

主要发现

  • 在预测<35周疑似子痫前期后14天内分娩方面,三种检测的AUC无显著差异(P=0.795)。
  • 三种检测的敏感性无显著差异(P=0.249)。
  • 三种检测的阳性预测值无显著差异(P=0.765)。
  • 三种检测的阴性预测值无显著差异(P=0.920)。
  • Elecsys sFlt-1/PlGF比值检测的特异性高于其他两种检测(P<0.001)。

临床怎么用

  • 作者结论认为三种检测预测表现相似,高阴性预测值支持PlGF检测作为子痫前期的排除工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the performance of three placental growth factor (PlGF)-based tests in predicting delivery within 14 days from testing in women with suspected preterm pre-eclampsia before 35 weeks' gestation. METHODS: This was a retrospective analysis of samples collected from three prospective pregnancy cohort studies. Participants were pregnant women with suspected preterm pre-eclampsia recruited in tertiary maternity units in the UK and Ireland. Samples were analyzed simultaneously according to the manufacturers' directions. The tests compared were the DELFIA Xpress PlGF 1-2-3 test, the Triage PlGF test and the Elecsys immunoassay soluble fms-like tyrosine kinase-1 (sFlt-1)/PlGF ratio. Areas under receiver-operating characteristics curves (AUCs) were compared. The main outcome measure was detection of a difference of 0.05 in AUC between tests for delivery within 14 days of testing. RESULTS: Plasma samples from 396 women and serum samples from 244 women were assayed. In predicting delivery within 14 days secondary to suspected pre-eclampsia prior to 35 weeks' gestation, no significant differences were observed in AUCs (P = 0.795), sensitivities (P = 0.249), positive predictive values (P = 0.765) or negative predictive values (P = 0.920) between the three tests. The specificity of the Elecsys sFlt-1/PlGF ratio test was higher than that of the other two tests (P < 0.001). CONCLUSIONS: The tests perform similarly in their prediction of need for delivery within 14 days in women with suspected pre-eclampsia. The high negative predictive values support the role of PlGF-based tests as 'rule-out' tests for pre-eclampsia. © 2018 Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. McCarthy FP, Gill C, Seed PT, et al. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study. Ultrasound Obstet Gynecol. 2018. PMID: 29575304. doi:10.1002/uog.19051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。